"
Team:Paris Bettencourt/Project/TMAU
From 2014.igem.org
| Line 196: | Line 196: | ||
</tr> | </tr> | ||
</table> | </table> | ||
| - | |||
<div id=part1 class=project> | <div id=part1 class=project> | ||
| + | <p class=text2></p> | ||
| + | <h6>Aims and Achievement</h6><br> | ||
| + | <p class=text1>The strain <i>Ruegeria pomeroyi</i>, a genus of the Rhodobacteraceae, produces an enzyme called trimethylamine monooxygenase thanks to the <i>tmm</i>(trimethylamine mono-oxygenase) gene. As FMO3, this enzyme degrades trimethylamine into trimethylamine-N-oxide but is adapted to a bacterial expression. The project aims at cloning <i>tmm</i> into <i>E.coli</i> and then into <i>Corynebacterium striatum</i>, one of the most common bacteria of the skin. The new strain would be integrated to the skin microbiome and would suppress the fish odor.</p> | ||
| + | </div> | ||
| + | <div id=part2 class=project> | ||
<p class=text2><img src='https://static.igem.org/mediawiki/2014/b/b3/Sch%C3%A9ma_fish_odor_syndrom.jpg' ></p> | <p class=text2><img src='https://static.igem.org/mediawiki/2014/b/b3/Sch%C3%A9ma_fish_odor_syndrom.jpg' ></p> | ||
<h6>Introduction</h6><br> | <h6>Introduction</h6><br> | ||
<p class=text1><a href="#ref1">Trimethylamine (TMA)</a> is produced in the intestine by <i>Desulfovibrio desulfuricans</i> by fermentation of choline. In healthy patients, the FMO3 gene allows the degradation of TMA in the liver into a non-volatile compound, TMA oxide. But a mutation in the FMO3 sequence is most of the time the cause of TMAU: TMA is not degraded and is then excreted in sweat, saliva and urine leading to a strong fish odor. The patients are otherwise healthy but the disease affect their social relationships and can lead to depression. There is no cure for this metabolic disorder but some treatments, often based on avoiding some sorts of food, tend to lower the symptoms</p> | <p class=text1><a href="#ref1">Trimethylamine (TMA)</a> is produced in the intestine by <i>Desulfovibrio desulfuricans</i> by fermentation of choline. In healthy patients, the FMO3 gene allows the degradation of TMA in the liver into a non-volatile compound, TMA oxide. But a mutation in the FMO3 sequence is most of the time the cause of TMAU: TMA is not degraded and is then excreted in sweat, saliva and urine leading to a strong fish odor. The patients are otherwise healthy but the disease affect their social relationships and can lead to depression. There is no cure for this metabolic disorder but some treatments, often based on avoiding some sorts of food, tend to lower the symptoms</p> | ||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
</div> | </div> | ||
<div id=part3 class=project> | <div id=part3 class=project> | ||
<p class=text2></p> | <p class=text2></p> | ||
| - | <h6> | + | <h6>Results</h6><br> |
| - | <p class=text1> | + | <p class=text1>After cloning <i>tmm</i>into a Biobrick vector (pSB1C3), the construct was successfully expressed in E.coli. TMM activity was found in E.coli pSB1C3-TMM (<i>tmm+</i>) but not in E.coli pSB1C3 (<i>tmm-</i>). TMM does not only degrade trimethylamine into trimethylamine-N-oxide, but also converts indole into indigo. To measure the activity of TMM, the growth medium was supplemented with tryptophan, a precursor of indole, which is the substrate of TMM. After 14h of culture, cells were pelleted, washed with water twice, and then resuspended in DMSO and sonicated. TMM activity was determined by measuring the absorbance spectrum of bacterial extractions. Peaks at 620 nm were found in <i>tmm+</i> cultures supplemented with tryptophan, which was identified as indigo according absorbance spectrum analysis.</p> |
</div> | </div> | ||
<div id=part4 class=project> | <div id=part4 class=project> | ||
<p class=text2></p> | <p class=text2></p> | ||
| - | <h6> | + | <h6>Methods</h6><br> |
| - | <p class=text1> | + | <p class=text1>Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut imperdiet diam eget quam imperdiet imperdiet. Mauris dapibus risus felis, sed ornare diam accumsan aliquet. Sed eu turpis porta, porttitor tortor et, condimentum augue. Curabitur a maximus nisi. Vivamus vitae magna ex. Donec congue auctor odio vitae tempus. In a gravida neque, et tristique tortor. Phasellus a odio sit amet enim ornare lobortis. Morbi sodales, diam non rutrum aliquam, ligula mauris consectetur urna, sed interdum quam risus sit amet enim. Aenean euismod enim magna, id pretium eros molestie non. Proin rutrum lobortis leo, sit amet congue erat. Nulla congue pellentesque augue porta dignissim. Pellentesque quis ex sollicitudin, condimentum risus varius, aliquet ipsum. Ut pulvinar aliquet maximus. Praesent imperdiet interdum commodo. </p> |
</div> | </div> | ||
<div id=reference> | <div id=reference> | ||
Revision as of 09:13, 15 October 2014
Something Fishy
| BACKGROUND Trimethylamine (TMA) is naturally produced in the gut by the intestinal flora and it is degraded in the liver by an enzyme called FMO3. Trimethylaminuria (TMAU), commonly called Fish Odor Syndrom, is a rare genetic disease occurring in patients that have the FMO3 gene mutated. TMA is then excreted in sweat, saliva and urine, causing a strong fish odor. |
AIMS Tmm (trimethylamine monooxygenase) is a gene found in the bacteria Ruegeria pomeroyi and it is similar to the human FMO3 gene. The aim of this project is to clone tmm into Corynebacterium striatum, a bacteria commonly found in the skin. This strain would be incorporated in a cosmetic cream in order to remove the fish odor in trimethylaminuria patients. |
RESULTS Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nunc convallis fringilla nunc, nec tristique neque. Praesent ut ante ultrices, dignissim nunc eget, interdum velit. Donec lobortis iaculis lorem, eget ornare quam finibus et. Vestibulum vehicula fringilla mauris, vitae feugiat ligula pharetra a. Duis fermentum neque vel dapibus accumsan. Quisque fringilla. |
| Introduction | Aims | Part3 | Part4 | Part5 |
Aims and Achievement
The strain Ruegeria pomeroyi, a genus of the Rhodobacteraceae, produces an enzyme called trimethylamine monooxygenase thanks to the tmm(trimethylamine mono-oxygenase) gene. As FMO3, this enzyme degrades trimethylamine into trimethylamine-N-oxide but is adapted to a bacterial expression. The project aims at cloning tmm into E.coli and then into Corynebacterium striatum, one of the most common bacteria of the skin. The new strain would be integrated to the skin microbiome and would suppress the fish odor.
Introduction
Trimethylamine (TMA) is produced in the intestine by Desulfovibrio desulfuricans by fermentation of choline. In healthy patients, the FMO3 gene allows the degradation of TMA in the liver into a non-volatile compound, TMA oxide. But a mutation in the FMO3 sequence is most of the time the cause of TMAU: TMA is not degraded and is then excreted in sweat, saliva and urine leading to a strong fish odor. The patients are otherwise healthy but the disease affect their social relationships and can lead to depression. There is no cure for this metabolic disorder but some treatments, often based on avoiding some sorts of food, tend to lower the symptoms
Results
After cloning tmminto a Biobrick vector (pSB1C3), the construct was successfully expressed in E.coli. TMM activity was found in E.coli pSB1C3-TMM (tmm+) but not in E.coli pSB1C3 (tmm-). TMM does not only degrade trimethylamine into trimethylamine-N-oxide, but also converts indole into indigo. To measure the activity of TMM, the growth medium was supplemented with tryptophan, a precursor of indole, which is the substrate of TMM. After 14h of culture, cells were pelleted, washed with water twice, and then resuspended in DMSO and sonicated. TMM activity was determined by measuring the absorbance spectrum of bacterial extractions. Peaks at 620 nm were found in tmm+ cultures supplemented with tryptophan, which was identified as indigo according absorbance spectrum analysis.
Methods
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut imperdiet diam eget quam imperdiet imperdiet. Mauris dapibus risus felis, sed ornare diam accumsan aliquet. Sed eu turpis porta, porttitor tortor et, condimentum augue. Curabitur a maximus nisi. Vivamus vitae magna ex. Donec congue auctor odio vitae tempus. In a gravida neque, et tristique tortor. Phasellus a odio sit amet enim ornare lobortis. Morbi sodales, diam non rutrum aliquam, ligula mauris consectetur urna, sed interdum quam risus sit amet enim. Aenean euismod enim magna, id pretium eros molestie non. Proin rutrum lobortis leo, sit amet congue erat. Nulla congue pellentesque augue porta dignissim. Pellentesque quis ex sollicitudin, condimentum risus varius, aliquet ipsum. Ut pulvinar aliquet maximus. Praesent imperdiet interdum commodo.
References
- ref1- ref2
+33 1 44 41 25 22/25
paris-bettencourt-igem@googlegroups.com 
